Study links genetic risk for brain conditions to changes in immune cell behaviour
Researchers at the Wellcome Sanger Institute, Open Targets and collaborators used lab-grown human brain immune cells, called microglia, to investigate how genetic differences affect their movement and ability to clear biological debris.
Using cells derived from 261 human stem cell lines, the team linked 34 genes to changes in cell behaviour. They also found that disabling TREM2, a gene associated with Alzheimer’s disease, increased debris clearance in microglia but reduced it in another immune cell type, highlighting how a gene’s effects depend on its cellular context.
The findings could help identify drug targets for neurological conditions, although this is laboratory research rather than a new treatment.
Credit: Medical Xpress | Wellcome Trust Sanger Institute
